KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash & Current Investments (2018 - 2025)

Aurinia Pharmaceuticals (AUPH) has disclosed Cash & Current Investments for 7 consecutive years, with $278.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments fell 20.11% year-over-year to $278.6 million, compared with a TTM value of $278.6 million through Dec 2025, down 22.28%, and an annual FY2024 reading of $358.5 million, up 2.28% over the prior year.
  • Cash & Current Investments was $278.6 million for Q3 2025 at Aurinia Pharmaceuticals, down from $315.1 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $466.1 million in Q4 2021 and bottomed at $278.6 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $350.6 million, with a median of $348.7 million recorded in 2024.
  • The sharpest move saw Cash & Current Investments soared 31.51% in 2022, then decreased 20.11% in 2025.
  • Year by year, Cash & Current Investments stood at $466.1 million in 2021, then dropped by 16.45% to $389.4 million in 2022, then dropped by 9.99% to $350.5 million in 2023, then increased by 2.28% to $358.5 million in 2024, then dropped by 22.28% to $278.6 million in 2025.
  • Business Quant data shows Cash & Current Investments for AUPH at $278.6 million in Q3 2025, $315.1 million in Q2 2025, and $312.9 million in Q1 2025.